We are live on ! Find out more
NRC

New Republic Capital Portfolio holdings

AUM $434M
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+31.16%
3 Year Est. Return
+91.38%
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
+$41.6M
Cap. Flow
+$38.3M
Cap. Flow %
19.21%
Top 10 Hldgs %
41.32%
Holding
260
New
40
Increased
117
Reduced
39
Closed
15

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$297K
2
IQV icon
IQVIA
IQV
+$271K
3
NKE icon
Nike
NKE
+$230K
4
PGR icon
Progressive
PGR
+$206K
5
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$185K

Sector Composition

Rank Sector Weight
1 Financials 18.75%
2 Technology 13.18%
3 Industrials 6.28%
4 Consumer Discretionary 4.87%
5 Healthcare 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
51
Netflix
NFLX
$307B
$738K 0.37%
10,940
+700
+7% +$43.7K
BAC icon
52
Bank of America
BAC
$441B
$735K 0.37%
18,479
-24
-0.1% -$920
JVAL icon
53
JPMorgan US Value Factor ETF
JVAL
$856M
$734K 0.37%
+17,964
New +$729K
XOM icon
54
ExxonMobil
XOM
$642B
$734K 0.37%
6,372
+1,781
+39% +$207K
CSX icon
55
CSX Corp
CSX
$93.9B
$733K 0.37%
21,915
-71
-0.3% -$2.41K
CAT icon
56
Caterpillar
CAT
$395B
$692K 0.35%
2,078
+23
+1% +$7.97K
CRM icon
57
Salesforce
CRM
$153B
$657K 0.33%
2,556
+437
+21% +$117K
CVX icon
58
Chevron
CVX
$371B
$650K 0.33%
4,158
+443
+12% +$70.6K
HCA icon
59
HCA Healthcare
HCA
$88.5B
$648K 0.33%
2,016
-31
-2% -$10.1K
GS icon
60
Goldman Sachs
GS
$301B
$642K 0.32%
1,420
+26
+2% +$11.4K
SPDW icon
61
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.2B
$638K 0.32%
18,200
ABBV icon
62
AbbVie
ABBV
$431B
$624K 0.31%
3,639
+26
+0.7% +$4.31K
JNJ icon
63
Johnson & Johnson
JNJ
$619B
$624K 0.31%
4,267
-345
-7% -$51.3K
TMO icon
64
Thermo Fisher Scientific
TMO
$214B
$619K 0.31%
1,118
+163
+17% +$93.4K
AMD icon
65
Advanced Micro Devices
AMD
$798B
$602K 0.3%
3,711
-20
-0.5% -$3.22K
VYMI icon
66
Vanguard International High Dividend Yield ETF
VYMI
$20.8B
$598K 0.3%
8,727
PEP icon
67
PepsiCo
PEP
$189B
$597K 0.3%
3,622
+691
+24% +$119K
EMXC icon
68
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.9B
$593K 0.3%
10,025
+68
+0.7% +$3.92K
ABT icon
69
Abbott
ABT
$187B
$591K 0.3%
5,683
+484
+9% +$51.3K
ACN icon
70
Accenture
ACN
$105B
$576K 0.29%
1,897
+276
+17% +$84.5K
MRK icon
71
Merck
MRK
$317B
$558K 0.28%
4,477
+93
+2% +$12K
VWO icon
72
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$556K 0.28%
12,717
CSCO icon
73
Cisco
CSCO
$476B
$548K 0.28%
11,544
-528
-4% -$25.1K
KO icon
74
Coca-Cola
KO
$374B
$544K 0.27%
8,490
+1,791
+27% +$111K
SHYG icon
75
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
$539K 0.27%
12,778

Similar funds

New Republic Capital's Q2 2024 Portfolio in Review

As of Q2 2024, New Republic Capital held 260 positions worth $199M, up 26% from $158M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

New Republic Capital deployed $38.3M of net new capital in Q2 2024, opening 40 new positions and adding to 117 existing holdings. Its largest new stake was JPMorgan US Value Factor ETF: 17,964 shares worth $734K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap ETF, an estimated $185K trimmed.

  • New Republic Capital's largest Q2 2024 buy was JPMorgan US Value Factor ETF: 17,964 shares worth $734K.
  • New Republic Capital added most to JPMorgan Chase in Q2 2024, an estimated $14.4M increase.
  • New Republic Capital's biggest Q2 2024 reduction was Vanguard Morningstar Mid-Cap ETF, cutting an estimated $185K.
  • New Republic Capital fully exited Intel in Q2 2024, selling an estimated $297K.
  • New Republic Capital's ten largest holdings make up 41% of its $199M portfolio in Q2 2024.
  • New Republic Capital opened 40 new positions and closed 15 in Q2 2024.
  • New Republic Capital's portfolio value rose 26% quarter-over-quarter to $199M.

Based on New Republic Capital's 13F filing for Q2 2024, filed 14 Aug 2024.